NCT05979597

Brief Summary

The investigators aimed to demonstrate that dexamethasone added as an adjuvant to local anaesthetic agent in suprainguinal fascia iliaca block for effective postoperative analgesia after knee arthroplasty would prolong the duration of sensory block and reduce postoperative pain intensity and analgesic consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 7, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

August 10, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2024

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

5 months

First QC Date

July 29, 2023

Last Update Submit

April 10, 2024

Conditions

Keywords

regional anesthesiasuprainguinal fascia iliaca blockdexamethasone

Outcome Measures

Primary Outcomes (1)

  • Postoperative opioid consumption

    First 24 hours total morphine consumption with patient controlled analgesia

    Postoperative 24 hours

Secondary Outcomes (3)

  • Numerical Rating Scale

    Postoperative 24 hours

  • Timed up and go test (TUG)

    at 24th hour

  • Quadriceps muscle strength

    at 24th hour

Study Arms (2)

Group SFIB (Suprainguinal fascia iliaca block)

ACTIVE COMPARATOR

In the patient lying in the supine position, a high-frequency linear probe is inserted under sterile conditions, using an in-plane technique, 1 cm cephalad of the inguinal ligament with a needle. Using hydro-dissection, the fascia iliaca is separated from the iliac muscle and a space is created where the needle can be advanced cranially, and the procedure will be completed by injecting local anesthetic into this space.

Procedure: Suprainguinal fascia iliaca block

Group SFIB+dexa (Suprainguinal fascia iliaca block+dexamethasone)

ACTIVE COMPARATOR

In the patient lying in the supine position, a high-frequency linear probe is inserted under sterile conditions, using an in-plane technique, 1 cm cephalad of the inguinal ligament with a needle. Using hydro-dissection, the fascia iliaca is separated from the iliac muscle and a space is created where the needle can be advanced cranially, and the procedure will be completed by injecting local anesthetic+dexamethasone into this space.

Procedure: Suprainguinal fascia iliaca block+dexamethasone

Interventions

After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic injection will be made between the fascia and the muscle.

Group SFIB (Suprainguinal fascia iliaca block)

After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic+dexamethasone injection will be made between the fascia and the muscle.

Group SFIB+dexa (Suprainguinal fascia iliaca block+dexamethasone)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having undergone unilateral knee replacement surgery under elective conditions,
  • Age range of 18-75 years,
  • American Society of Anesthesiologist's physiologic state I-III patients,
  • written consent who agreed to participate in the study.

You may not qualify if:

  • BMI\>35
  • who do not want to be included in the study by not signing the voluntary consent form,
  • Local infection, hematoma, hernia, neoplasm etc. in the area to be blocked. found,
  • Coagulopathy, hepatic or renal failure,
  • Allergic to a local anesthetic agent or one of the drugs used in the study,
  • Having a history of chronic opioid and corticosteroid use,
  • who cannot use the patient-controlled analgesia system and have a psychiatric disease,
  • with operative time less than 20 minutes and more than 120 minutes for better standardization of studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsun Research and Education Hospital

Samsun, 55090, Turkey (Türkiye)

Location

Related Publications (4)

  • Seo SS, Kim OG, Seo JH, Kim DH, Kim YG, Park BY. Comparison of the Effect of Continuous Femoral Nerve Block and Adductor Canal Block after Primary Total Knee Arthroplasty. Clin Orthop Surg. 2017 Sep;9(3):303-309. doi: 10.4055/cios.2017.9.3.303. Epub 2017 Aug 4.

  • Desmet M, Balocco AL, Van Belleghem V. Fascia iliaca compartment blocks: Different techniques and review of the literature. Best Pract Res Clin Anaesthesiol. 2019 Mar;33(1):57-66. doi: 10.1016/j.bpa.2019.03.004. Epub 2019 Apr 17.

  • Vermeylen K, Soetens F, Leunen I, Hadzic A, Van Boxtael S, Pomes J, Prats-Galino A, Van de Velde M, Neyrinck A, Sala-Blanch X. The effect of the volume of supra-inguinal injected solution on the spread of the injectate under the fascia iliaca: a preliminary study. J Anesth. 2018 Dec;32(6):908-913. doi: 10.1007/s00540-018-2558-9. Epub 2018 Sep 24.

  • Pehora C, Pearson AM, Kaushal A, Crawford MW, Johnston B. Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011770. doi: 10.1002/14651858.CD011770.pub2.

Study Officials

  • Mustafa Süren, Professor

    Samsun Research and Education Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
The patient will not know which study group he is in. The anesthetist, who will perform the regional block, will give the block to be applied in a sealed envelope by an assistant staff outside the study, and at the same time, the patient will not know which block has been made. The anesthesiologist who made the block will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another investigator blinded to the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist, Principal Investigator

Study Record Dates

First Submitted

July 29, 2023

First Posted

August 7, 2023

Study Start

August 10, 2023

Primary Completion

December 31, 2023

Study Completion

January 15, 2024

Last Updated

April 11, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Researched data and statistical analyzes will be available from the journal in which the clinical study was published

Locations